Shelton Capital Management Personalis, Inc. Transaction History

Shelton Capital Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$2.89 - $5.32 $18,207 - $33,516	-6,300 Reduced 14.34%	37,624 $112,000
Q1 2022 May 12, 2022	SELL	$7.56 - $14.3 $401,254 - $758,986	-53,076 Reduced 54.72%	43,924 $360,000
Q4 2021 Feb 11, 2022	BUY	$12.24 - $21.25 $146,880 - $255,000	12,000 Added 14.12%	97,000 $1.38 Million
Q3 2021 Nov 15, 2021	BUY	$16.69 - $26.05 $584,150 - $911,750	35,000 Added 70.0%	85,000 $1.64 Million
Q1 2021 May 14, 2021	BUY	$20.71 - $51.02 $1.04 Million - $2.55 Million	50,000 New	50,000 $1.23 Million

30.1M

27.5K

85.4K

Ticker PSNL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 45,918,400
Market Cap $159M
Description
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

Stay updated on Shelton Capital Management with notifications on news.